Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Comparative-Effectiveness Policies Gaining Momentum In Washington

This article was originally published in The Gray Sheet

Executive Summary

Funding comparative-effectiveness research to slow growth in health care spending is building momentum this year among health policy and payor circles

Related Content

Comparative Effectiveness Could Spur Growth Of Lab Tests, Consultant Says
Device Makers Cite Special Concerns With Comparative Effectiveness
Device Industry Looks To SCHIP Bill For Medicare Reforms
House Bill Targets Imaging Payments To Help Fund Children’s Insurance
Talking To Tunis: Former CMS Medical Chief Works To Improve Tech Studies
Savings From Comparative Effectiveness Entity Could Be Decade Away – CBO
Renal Stenting Coverage Reconsidered: AHRQ Comparative Analysis Effect
Medicare Experts Mull Idea Of U.S. Comparative Effectiveness Review Agency
Public-Private Comparative Effectiveness Body Needed – Ex-Medicare Chief
Public-Private Comparative Effectiveness Body Needed – Ex-Medicare Chief



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts